ライフサイエンスコーパス: stent-graft

1 t with an endovascular bifurcated aortoiliac stent graft.

2 astin-poor neointima incorporated the entire stent graft.

3 or balloon angioplasty plus placement of the stent graft.

4 the implantation of a self-expanding nitinol stent graft.

5 bdominal aortic aneurysm with an endoluminal stent graft.

6 have undergone AAA exclusion with the AneuRx stent-graft.

7 ted in an endovascular suite with the AneuRx stent-graft.

8 red red and white blood cells adhered to the stent-graft.

9 air by means of placement of an endovascular stent-graft.

10 superior to that after TIPS with the nitinol stent-graft.

11 e same procedure by placing a second nitinol stent-graft.

12 o determine the long-term performance of the stent-graft.

13 e patients after placement of an aortobiliac stent-graft.

14 rd the use of endovascular bifurcated aortic stent grafts.

15 successfully with two heparin-bonded covered stent grafts.

16 nts prior to transfemoral delivery of aortic stent-grafts.

17 th prediction for 31 AneuRx and two Excluder stent-grafts.

18 ent of aortoiliac aneurysms with endoluminal stent-grafts.

19 t-graft that did not narrow the lumen of the stent-grafts.

20 rtic aneurysm were treated with endovascular stent-grafts.

21 tinol polytetrafluoroethylene (PTFE)-covered stent-grafts.

22 owing treatment of aortoiliac aneurysms with stent-grafts.

23 were successfully treated with endovascular stent grafting.

24 of thoracic aortic aneurysms by endovascular stent-grafting.

25 US centers preferentially used Zenith stent-grafts (54.2%) and European centers Endurant stent

26 grafts (54.2%) and European centers Endurant stent-grafts (62.2%) for the main body component.

27 omplications triggered the implantation of a stent graft (86.5%), mainly because of bleeding (90.6%)

28 CT) angiograms in 158 patients who underwent stent-graft AAA repair were retrospectively reviewed to

29 We studied the placement of endovascular stent-grafts across the primary entry tear for the manag

30 Placement of endovascular stent-grafts across the primary entry tears was technica

31 evaluation are correct sizing of the aortic stent-graft and localization of the artery of Adamkiewic

32 ndromes, peripheral vascular disease, aortic stent-graft and transcatheter aortic valve assessment, a

33 lexible PTFE-encapsulated balloon-expandable stent-grafts and four control TIPS with bare Wallstents)

34 morphological changes and PDGF expression in stented grafts and contralateral unstented grafts in the

35 novel angioplasty balloons; nitinol stents, stent grafts, and drug-eluting stents; excisional, laser

36 egies for ASARVI include manual compression, stent grafts, and vascular surgery.

37 sfully excluded by implantation of a covered stent-graft, and 10 patients necessitated surgical inter

38 l proliferation were sustained in externally stented grafts, and these effects were associated with a

39 graft stents were placed in 11 patients, and stent-graft angioplasty alone was performed in one patie

40 Endovascular stent grafts are likely to be increasingly deployed, and

41 rgical repair, and endoluminal deployment of stent-grafts are new developments that provide new optio

42 PTFE stent-grafts can markedly prolong TIPS patency, potentia

43 reatment for endoleak in eight patients, and stent-graft collapse or infolding in six patients.

44 ificantly higher with self-expanding covered stent grafts compared with bare-metal stents (10.6% vers

45 ontrast) and clear understanding of specific stent-graft components and placement.

46 primary unassisted patency in patients with stent-grafts confined to the parenchymal tract was 75% +

47 Current generation stent grafts correlated with significantly improved outc

48 The mean total hospital cost (including stent-graft costs and excluding attending physician fees

49 These initial results suggest that stent-graft coverage of the primary entry tear may be a

50 ing two procedures because of failure of the stent-graft delivery system.

51 The technical challenges of stent graft deployment in the descending thoracic aorta,

52 eratively and during the intervention before stent-graft deployment and relative hypertension after d

53 Following stent-graft deployment, helical CT data were analyzed fo

54 angiographers, who were not involved in the stent-graft deployment, interpreted the conventional ang

55 ed with the aortoiliac arterial length after stent-graft deployment.

56 clopidogrel bolus was administered prior to stent-graft deployment.

57 the clopidogrel bolus was administered after stent-graft deployment.

58 tients underwent EVAR utilizing 10 different stent graft devices.

59 Patients received 1 of 12 different stent graft devices.

60 cular treatment of aortoiliac aneurysms with stent-graft devices may be an alternative to surgery.

61 of 16 patients who received a Dacron-covered stent-graft during revision or de novo creation of TIPS.

62 On November 23, 1992, the first endovascular stent graft (ESG) repair of an aortic aneurysm was perfo

63 ct was 75% +/- 22, and that of patients with stent-grafts extending at least 1 cm into the portal vei

64 xpanded polytetrafluoroethylene endovascular stent graft for revision of venous anastomotic stenosis

65 ed that the standard use of a self-expanding stent graft for the management of ASARVI is feasible and

66 dministration has approved four endovascular stent grafts for the treatment of abdominal aortic aneur

67 , W.L. Gore and Associates, Flagstaff, Ariz) stent-graft for direct intrahepatic portacaval shunt (DI

68 y useful in the construction of endovascular stent-grafts for use in human arteries.

69 Three patients underwent additional aortic stent grafting, four patients underwent placement of an

70 A Viatorr((R)) stent-graft (Gore, Flagstaff, AR, USA) is an endoprosthe

71 in the balloon-angioplasty group than in the stent-graft group (78% vs. 28%, P<0.001).

72 atment area was significantly greater in the stent-graft group than in the balloon-angioplasty group

73 at 6 months was significantly greater in the stent-graft group than in the balloon-angioplasty group

74 ative analysis of the several of the various stent grafts has been performed.

75 the advent of endovascular therapies such as stent-grafting has broadened the base of practitioners c

76 fter successful treatment using endovascular stent graft implantation.

77 per patient, necessity of additional aortic stent-graft implantation and/or placement of a bare meta

78 t a giant celiac pseudoaneurysm treated with stent-graft implantation.

79 Routine use of a self-expanding nitinol stent graft in selected patients experiencing ASARVI aft

80 inical effectiveness of the Medtronic AneuRx stent-graft in patients with infrarenal abdominal aortic

81 asis in six (10%), mural thrombus within the stent-graft in two (3%), and new aortic dissection in on

82 rs after elective TEVAR were associated with stent graft induced false lumen thrombosis in 90.6% of c

83 spring stent grafts with direct evidence of stent graft-induced injury at surgery or necropsy in hal

84 is useful in the treatment of patients after stent-graft insertion for the management of descending t

85 neurysm was 58.8 mm before and 60.0 mm after stent-graft insertion.

86 Endovascular stent grafting is performed in patients with aneurysms o

87 This PTFE-encapsulated stent-graft is biocompatible and safe to place.

88 main drawbacks of the use of e-PTFE covered stent-graft is higher incidence of hepatic encephalopath

89 aortic occlusion and placement of the aortic stent-graft is mandatory.

90 Placement of a fully supported stent-graft is necessary to repair an aortoiliac aneurys

91 ment of carotid pseudoaneurysms with covered stent-grafts is a safe and efficient method providing de

92 Transluminal placement of endovascular stent-grafts is a technically feasible method for treatm

93 Causes of rAAD included the stent graft itself (60%), manipulation of guide wires/sh

94 from the vessel wall most accurately enabled stent-graft length prediction for 31 AneuRx and two Excl

95 Endoleaks represent blood flow outside the stent-graft lumen but within the aneurysm sac.

96 Type I collagen as a intravascular stent-graft material is biocompatible for at least 3 mon

97 Patients undergoing endovascular stent grafting may benefit from risk stratification with

98 Surgeon-modified fenestrated stent grafts may be a viable option for selected high-su

99 stances of pulmonary failure, renal failure, stent-graft migration, or late leakage.

100 ched EVAR (n=8), and visceral deviation with stent grafting (n=7); no deaths occurred intraoperativel

101 Either a prototype stent-graft (n = 6) or Wallgraft (n = 2) was used to cre

102 patients who underwent de novo placement of stent-grafts (n = 10) was compared with that of patients

103 Endovascular stent grafting of aneurismal disease processes of the th

104 five patients after placement of additional stent-grafts or coil embolization to treat perigraft lea

105 Placement of a stent-graft over the entry tear was the most effective m

106 10) was compared with that of patients with stent-grafts placed during shunt revision (n = 6); in al

107 t placement was 90% +/- 9, whereas that with stent-grafts placed during TIPS revision was 17% +/- 15

108 Two patients had undergone stent graft placement and had short, wide tracts.

109 ic dilation was not observed at 1 year after stent graft placement within AADs with patent side branc

110 After stent graft placement, the stent struts and the graft we

111 not form in the AAD until immediately after stent graft placement; flow arrest occurred in the space

112 Stent-graft placement and thrombosis of the aneurysmal s

113 Primary unassisted patency rates following stent-graft placement at 4, 12, and 24 months (+/- stand

114 After stent-graft placement in the 63 patients, CT demonstrate

115 y, safety, and effectiveness of transluminal stent-graft placement over the entry tear in 4 patients

116 In six cases, prior to stent-graft placement persistent biliary-TIPS fistulas w

117 ths, primary unassisted patency with de novo stent-graft placement was 90% +/- 9, whereas that with s

118 ents with thoracic aortic aneurysm underwent stent-graft placement.

119 The first 25,000 stent-graft procedures have been attended by significant

120 The use of endovascular stent-graft prosthesis for the treatment of AAAs is rece

121 All stent-grafts remained patent without increased aneurysma

122 Two years prior, the patient had undergone a stent graft repair of the thoracic aorta at the local va

123 mplication of open surgical and endovascular stent graft repair of thoracic and thoracoabdominal aort

124 early total and type 2 endoleak rates after stent-graft repair of AAAs; thus, patent sac branches pl

125 s more stable than conventional endovascular stent graft repairs, post-implantation movement of the e

126 Preliminary evidence suggests that stent grafts represent an important noninvasive option.

127 cant advances have also occurred recently in stent graft research and development.

128 Transrenal fixation of aortic stent-grafts seems to be a relatively safe alternative c

129 toiliac endovascular stent-grafts to correct stent-graft stenosis and preserve long-term function.

130 The introduction of endovascular stent graft technology has ushered in a new era in thera

131 uminal exclusion of blood flow effected with stent graft technology.

132 Recent innovations in thoracic stent-graft technology have facilitated methods of repla

133 porary patients treated with just a standard stent graft that costs were significantly lower in 21 Ou

134 gen deposition within the interstices of the stent-graft that did not narrow the lumen of the stent-g

135 nly studies on transrenal fixation of aortic stent-grafts that included follow-up results for renal f

136 Stent graft therapy for aortic aneurysms is a valuable a

137 number of angiograms required to deploy the stent graft, thereby reducing delays.

138 e introduction of a dedicated e-PTFE covered stent-graft, these problems were completely solved, No m

139 One patient developed stent-graft thrombosis; the prior biliary-TIPS fistula w

140 In selecting the specific stent graft to be used for endovascular abdominal aortic

141 Previous studies used covered stent grafts to treat abdominal aortic aneurysms; howeve

142 Larger series of fenestrated stent grafts to treat juxtarenal aneurysms have been pub

143 e required in 31% of aortoiliac endovascular stent-grafts to correct stent-graft stenosis and preserv

144 e, and highlights the recent developments in stent graft treatment of abdominal aortic aneurysms.

145 test the effect of closing the entry tear, a stent-graft was deployed over the entry tear under physi

146 At 1 month, the stent-graft was endothelialized and was infiltrated with

147 The portion of the aorta containing the stent-graft was excised and was histologically evaluated

148 re favorable outcomes were observed when the stent-graft was placed during de novo TIPS creation and

149 DIPS creation with the nitinol PTFE-covered stent-graft was superior to that after TIPS with the nit

150 Patients receiving stent grafts were more often female (62.2 versus 45.6%,

151 ic arteries followed by aortic relining with stent grafts were reviewed and tabulated.

152 Stent grafts were successfully implanted in 116 (95%) in

153 nal (n = 46) aortic aneurysms treated with a stent-graft were prospectively included.

154 Stent-grafts were constructed from modified Z-stents cov

155 nneled between both flank access points, and stent-grafts were deployed from each of the renal origin

156 Stent-grafts were dilated up to 14 mm (iliac) and 24 mm

157 Stent-grafts were implanted in a group of 18 dogs with a

158 Aortouniiliac stent-grafts were inserted in 42 patients and aortoaorti

159 Stent-grafts were inserted through surgically exposed fe

160 The stent-grafts were made of self-expanding stainless-steel

161 All stent-grafts were patent at all time points.

162 served among patients in whom Dacron-covered stent-grafts were placed during revision or de novo crea

163 Stent-grafts were placed successfully in all cases.

164 ing shunt revision (n = 6); in all patients, stent-grafts were placed within stents.

165 The stent-grafts were readily deployed in all cases.

166 All stent-grafts were successfully deployed, and endoleaks w

167 Stent-grafts were successfully placed in all 11 cases.

168 ialysis graft was improved with the use of a stent graft, which appears to provide longer-term and su

169 ociated with the use of proximal bare spring stent grafts with direct evidence of stent graft-induced

170 Stent grafts with proximal bare springs were used in maj

171 A composite nitinol-collagen endovascular stent-graft with a 4-mm inner diameter was deployed in t